tiprankstipranks
Advertisement
Advertisement
Jupiter Neurosciences Stockholders Approve Key 2026 Actions
PremiumCompany AnnouncementsJupiter Neurosciences Stockholders Approve Key 2026 Actions
17d ago
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
Premium
The Fly
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
21d ago
Jupiter Neurosciences Licenses ALA-002 for U.S. Development
Premium
Company Announcements
Jupiter Neurosciences Licenses ALA-002 for U.S. Development
23d ago
Jupiter Neurosciences Announces Board Member Resignation and Vacancy
PremiumCompany AnnouncementsJupiter Neurosciences Announces Board Member Resignation and Vacancy
2M ago
Jupiter Neurosciences Promotes Silva to COO and President
Premium
Company Announcements
Jupiter Neurosciences Promotes Silva to COO and President
2M ago
Jupiter Neurosciences commences patient enrollment in RESET trial
Premium
The Fly
Jupiter Neurosciences commences patient enrollment in RESET trial
3M ago
Jupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront
PremiumThe FlyJupiter Neurosciences to acquire licensing rights to ALA-002 for $3.33M upfront
3M ago
Jupiter Neurosciences Delays Annual 10-K Filing
Premium
Company Announcements
Jupiter Neurosciences Delays Annual 10-K Filing
4M ago
Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting
Premium
Company Announcements
Jupiter Neurosciences Receives Nasdaq Deficiency Notices, Faces Delisting
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100